Initial medical trials of another corona virus vaccine have been successfully completed in the United States. The experiments were performed on 45 healthy people between the ages of 18 and 55. The vaccine was invented by the international pharmaceutical company Pfizer, while the latest “RNA gene technology” has been used in its preparation.
According to details published in the latest issue of the research journal Nature, the vaccine has been given the temporary name BNT162b1 and participants in the medical trials were given two doses of 10 micrograms and 30 micrograms, respectively.
Experts who developed the vaccine say that the vaccine is very effective because it contains a special type of RNA called “messenger RNA” (mRNA).
Made in a specific structure with the help of genetic engineering, this messenger RNA develops instant immunity against the novel corona virus in the human body and whenever the virus attacks the person concerned, the body’s immune system reacts immediately. Thwarts this attack by taking action.
Your email address will not be published. Required fields are marked *